Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Wortmann

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Clinics in Dermatology|September 13, 2006
DermatomyositisJeffrey P Callen, Robert L Wortmann
Lancet (London, England)|August 20, 2010
Gout therapeutics: new drugs for an old diseaseChristopher M Burns, Robert L Wortmann
Postgraduate Medicine|January 17, 2013
Hyperuricemia and gout: new concepts in diagnosis and managementPaul P Doghramji, Robert L Wortmann
Rheumatic Diseases Clinics of North America|April 20, 2013
Noninflammatory myopathiesAlan N Baer, Robert L Wortmann
Therapeutic Advances in Chronic Disease|January 24, 2013
Latest evidence on gout management: what the clinician needs to knowChristopher M Burns, Robert L Wortmann
Current Opinion in Rheumatology|December 5, 2006
Myotoxicity associated with lipid-lowering drugsAlan N Baer, Robert L Wortmann
Bulletin of the NYU Hospital for Joint Diseases|December 17, 2009
Drug-induced myopathiesAdam Mor, Hal J Mitnick, Michael H Pillinger, et al.
Rheumatic Diseases Clinics of North America|March 30, 2011
Drugs causing muscle diseaseAdam Mor, Robert L Wortmann, Hal J Mitnick, et al.
Clinical Therapeutics|March 1, 2011
Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trialsRobert L Wortmann, Patricia A Macdonald, Barbara Hunt, et al.
Seminars in Arthritis and Rheumatism|January 2, 2008
Drug-induced arthritic and connective tissue disordersAdam Mor, Michael H Pillinger, Robert L Wortmann, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Clinics in Dermatology|September 13, 2006
DermatomyositisJeffrey P Callen, Robert L Wortmann
Lancet (London, England)|August 20, 2010
Gout therapeutics: new drugs for an old diseaseChristopher M Burns, Robert L Wortmann
Postgraduate Medicine|January 17, 2013
Hyperuricemia and gout: new concepts in diagnosis and managementPaul P Doghramji, Robert L Wortmann
Rheumatic Diseases Clinics of North America|April 20, 2013
Noninflammatory myopathiesAlan N Baer, Robert L Wortmann
Therapeutic Advances in Chronic Disease|January 24, 2013
Latest evidence on gout management: what the clinician needs to knowChristopher M Burns, Robert L Wortmann
Current Opinion in Rheumatology|December 5, 2006
Myotoxicity associated with lipid-lowering drugsAlan N Baer, Robert L Wortmann
Bulletin of the NYU Hospital for Joint Diseases|December 17, 2009
Drug-induced myopathiesAdam Mor, Hal J Mitnick, Michael H Pillinger, et al.
Rheumatic Diseases Clinics of North America|March 30, 2011
Drugs causing muscle diseaseAdam Mor, Robert L Wortmann, Hal J Mitnick, et al.
Clinical Therapeutics|March 1, 2011
Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trialsRobert L Wortmann, Patricia A Macdonald, Barbara Hunt, et al.
Seminars in Arthritis and Rheumatism|January 2, 2008
Drug-induced arthritic and connective tissue disordersAdam Mor, Michael H Pillinger, Robert L Wortmann, et al.
Pageof 4